Heart Disease and Diabetes

Cardiovascular disease is a common cause of morbidity and mortality in people with diabetes, and it is an issue that is becoming increasingly important to both cardiologists and specialists in diabetes. The routine management of patients with diabetes now includes close attention to the methods to control hyperglycaemia that give maximum reduction in cardiovascular events. This pocketbook details the complications that diabetes presents in relation to heart disease, introduces the reader to various risk factors and discusses the possible treatments that can be explored. This second edition has also been updated throughout to include new trial data, new drugs and updates on treatment of diabetes in heart failure patients. The information in this book is presented in an easy to use format, and supplemented with key figures, tables and summarized research findings.

1 - Introduction, epidemiology, and cardiovascular risk factors
2 - Hyperglycaemia and weight management
3 - Diabetic dyslipidaemia
4 - Hypertension in diabetes
5 - Coronary heart disease in diabetes
6 - Acute coronary syndromes in diabetes
7 - Coronary revascularization in the patient with diabetes
8 - Chronic heart failure in diabetes
9 - Other vascular disease in diabetes
10 - Diabetic nephropathy
11 - Diabetic autonomic neuropathy and sudden death in diabetes
12 - Health economic aspects of treating cardiovascular disease in diabetes

Miles Fisher graduated from Glasgow University in 1979. He worked as a research fellow in the Department of Diabetes in Gartnavel General Hospital in the 1980s, where his interests were diabetes and the heart, and hypoglycaemia. He received his MD in 1988 for his thesis on 'Evidence for a diabetic cardiopathy.' From 1992-2001 he was a consultant physician at the Royal Alexandra Hospital, Paisley, and since 2001 has been a consultant physician at Glasgow Royal Infirmary. In 2010 he was made an Honorary Professor in the University of Glasgow. He was on the steering committee of the DIGAMI 2 study and was the Scottish co-ordinator. He was an events adjudicator for the HOPE and HOPE-TOO studies and is currently an events adjudicator for the ACE Trial. Miles Fisher is the author or co-author of over 130 original papers and review articles. He is the editor or co-editor of four books on heart disease in diabetes, and two books on hypoglycaemia.